Published in PLoS One on September 04, 2014
Short-term exposure to engineered nanomaterials affects cellular epigenome. Nanotoxicology (2015) 0.87
Investigating the Role of TNF-α and IFN-γ Activation on the Dynamics of iNOS Gene Expression in LPS Stimulated Macrophages. PLoS One (2016) 0.79
Host Antimicrobial Peptides in Bacterial Homeostasis and Pathogenesis of Disease. Antibiotics (Basel) (2014) 0.78
Epithelial cells from oral mucosa: How to cultivate them? Cytotechnology (2016) 0.75
Protective effect of in ovo treatment with the chicken cathelicidin analog D-CATH-2 against avian pathogenic E. coli. Sci Rep (2016) 0.75
The mechanism of human β-defensin 3 in MRSA-induced infection of implant drug-resistant bacteria biofilm in the mouse tibial bone marrow. Exp Ther Med (2017) 0.75
Evaluation of the role of human β-defensin 3 in modulation of immunity and inflammatory response after knee replacement. Exp Ther Med (2017) 0.75
Antimicrobial efficacy against Pseudomonas aeruginosa biofilm formation in a three-dimensional lung epithelial model and the influence of fetal bovine serum. Sci Rep (2017) 0.75
Gingival crevicular fluid and serum hCAP18/LL-37 levels in generalized aggressive periodontitis. Clin Oral Investig (2016) 0.75
Procedure for isolation of bacterial lipopolysaccharides from both smooth and rough Pseudomonas aeruginosa and Salmonella typhimurium strains. J Bacteriol (1983) 8.19
Periodontal microbial ecology. Periodontol 2000 (2005) 5.67
LL-37, the only human member of the cathelicidin family of antimicrobial peptides. Biochim Biophys Acta (2006) 3.05
Human CAP18: a novel antimicrobial lipopolysaccharide-binding protein. Infect Immun (1995) 2.87
Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis in human periodontal disease: occurrence and treatment. Periodontol 2000 (1999) 2.64
The human antimicrobial peptide LL-37 is a multifunctional modulator of innate immune responses. J Immunol (2002) 2.57
Modulation of the TLR-mediated inflammatory response by the endogenous human host defense peptide LL-37. J Immunol (2006) 2.32
Virulence factors of Actinobacillus actinomycetemcomitans. Periodontol 2000 (1999) 1.94
Periodontal disease as a specific, albeit chronic, infection: diagnosis and treatment. Clin Microbiol Rev (2001) 1.94
The roles of cathelicidin LL-37 in immune defences and novel clinical applications. Curr Opin Hematol (2009) 1.92
Human beta-defensins 2 and 3 demonstrate strain-selective activity against oral microorganisms. J Clin Microbiol (2004) 1.91
Staphylococcus aureus susceptibility to innate antimicrobial peptides, beta-defensins and CAP18, expressed by human keratinocytes. Infect Immun (2003) 1.90
Endotoxin (lipopolysaccharide) neutralization by innate immunity host-defense peptides. Peptide properties and plausible modes of action. J Biol Chem (2005) 1.72
Synergistic actions of antibacterial neutrophil defensins and cathelicidins. Inflamm Res (2000) 1.67
Human defensins and LL-37 in mucosal immunity. J Leukoc Biol (2009) 1.67
Mutual induction of growth factor gene expression by epidermal-dermal cell interaction. J Cell Biol (1993) 1.60
Synergistic effect of antibacterial agents human beta-defensins, cathelicidin LL-37 and lysozyme against Staphylococcus aureus and Escherichia coli. J Dermatol Sci (2005) 1.53
Real-time attack on single Escherichia coli cells by the human antimicrobial peptide LL-37. Proc Natl Acad Sci U S A (2011) 1.48
The novel human beta-defensin-3 is widely expressed in oral tissues. Eur J Oral Sci (2002) 1.43
Biological properties of structurally related alpha-helical cationic antimicrobial peptides. Infect Immun (1999) 1.40
Human gingival epithelial cells produce chemotactic factors interleukin-8 and monocyte chemoattractant protein-1 after stimulation with Porphyromonas gingivalis via toll-like receptor 2. J Periodontol (2004) 1.33
Antimicrobial peptides of the oral cavity. Periodontol 2000 (2009) 1.31
Antimicrobial peptides important in innate immunity. FEBS J (2011) 1.30
Human beta-defensin 3 has immunosuppressive activity in vitro and in vivo. Eur J Immunol (2010) 1.26
Secretion of IL-1 beta, TNF-alpha, IL-8 and IL-1ra by human polymorphonuclear leukocytes in response to lipopolysaccharides from periodontopathic bacteria. J Periodontal Res (1997) 1.26
Inflammatory mediators in the pathogenesis of periodontitis. Expert Rev Mol Med (2013) 1.25
Human beta-defensin 3 binds to hemagglutinin B (rHagB), a non-fimbrial adhesin from Porphyromonas gingivalis, and attenuates a pro-inflammatory cytokine response. Immunol Cell Biol (2008) 1.20
Salivary antimicrobial peptide expression and dental caries experience in children. Antimicrob Agents Chemother (2005) 1.19
Degradation of human alpha- and beta-defensins by culture supernatants of Porphyromonas gingivalis strain 381. J Innate Immun (2008) 1.14
Polymorphonuclear neutrophils and their mediators in gingival tissues from generalized aggressive periodontitis. J Periodontol (2001) 1.12
A multiplex immunoassay demonstrates reductions in gingival crevicular fluid cytokines following initial periodontal therapy. J Periodontal Res (2009) 1.12
Innate immune responses of gingival epithelial cells to nonperiodontopathic and periodontopathic bacteria. J Periodontal Res (2007) 1.09
Activity of human beta-defensin 3 alone or combined with other antimicrobial agents against oral bacteria. Antimicrob Agents Chemother (2003) 1.06
Antimicrobial peptides and periodontal disease. J Clin Periodontol (2011) 1.05
Host-response therapeutics for periodontal diseases. J Periodontol (2008) 1.05
Expression of human beta-defensin-3 in gingival epithelia. J Periodontal Res (2005) 1.02
Characterization of cellular infiltrate, detection of chemokine receptor CCR5 and interleukin-8 and RANTES chemokines in adult periodontitis. J Periodontal Res (2001) 1.02
Expression of defensins in gingiva and their role in periodontal health and disease. Curr Pharm Des (2007) 1.01
Production of inflammatory mediators and cytokines by human gingival fibroblasts following bacterial challenge. J Periodontal Res (1996) 1.00
Differential induction of human beta-defensin expression by periodontal commensals and pathogens in periodontal pocket epithelial cells. J Periodontol (2005) 1.00
Gingival crevicular fluid levels of monocyte chemoattractant protein-1 and tumor necrosis factor-alpha in patients with chronic and aggressive periodontitis. J Periodontol (2005) 0.99
Mesenchyme-mediated and endogenous regulation of growth and differentiation of human skin keratinocytes derived from different body sites. Differentiation (1990) 0.96
Anti-inflammatory activity of a high-molecular-weight cranberry fraction on macrophages stimulated by lipopolysaccharides from periodontopathogens. J Dent Res (2006) 0.94
Regulation of cytokine production in human gingival fibroblasts following treatment with nicotine and lipopolysaccharide. J Periodontol (2001) 0.92
Epithelial cell-derived antimicrobial peptides are multifunctional agents that bridge innate and adaptive immunity. Periodontol 2000 (2010) 0.92
Antimicrobial peptides in periodontal innate defense. Front Oral Biol (2011) 0.91
Structural, regulatory, and functional studies of the GRO gene and protein. Cytokines (1992) 0.90
Correlation of gingival crevicular fluid interleukin-18 and monocyte chemoattractant protein-1 levels in periodontal health and disease. J Periodontol (2009) 0.90
Inflammatory mediators and the destruction of bone. J Periodontal Res (1991) 0.90
Gingipains produced by Porphyromonas gingivalis ATCC49417 degrade human-β-defensin 3 and affect peptide's antibacterial activity in vitro. Peptides (2011) 0.89
Antibacterial and lipopolysaccharide (LPS)-neutralising activity of human cationic antimicrobial peptides against periodontopathogens. Int J Antimicrob Agents (2009) 0.87
Understanding the roles of gingival beta-defensins. J Oral Microbiol (2012) 0.86
Cathelicidin LL-37: LPS-neutralizing, pleiotropic peptide. Ann Agric Environ Med (2007) 0.86
Susceptibility of periodontopathogenic and cariogenic bacteria to defensins and potential therapeutic use of defensins in oral diseases. Curr Pharm Des (2007) 0.86
Effect of the antimicrobial peptide LL-37 on Toll-like receptors 2-, 3- and 4-triggered expression of IL-6, IL-8 and CXCL10 in human gingival fibroblasts. Cell Immunol (2010) 0.85
MyD88 is essential for alveolar bone loss induced by Aggregatibacter actinomycetemcomitans lipopolysaccharide in mice. Mol Oral Microbiol (2013) 0.85
Salivary LL-37 secretion in individuals with Down syndrome is normal. J Dent Res (2006) 0.85
A novel organotypic dento-epithelial culture model: effect of Fusobacterium nucleatum biofilm on B-defensin-2, -3, and LL-37 expression. J Periodontol (2011) 0.84
Nicotine and lipopolysaccharide affect cytokine expression from gingival fibroblasts. J Periodontol (2007) 0.82
Suppressive effect of the antimicrobial peptide LL-37 on expression of IL-6, IL-8 and CXCL10 induced by Porphyromonas gingivalis cells and extracts in human gingival fibroblasts. Eur J Oral Sci (2010) 0.81
Antibacterial and neutralizing effect of human β-defensins on Enterococcus faecalis and Enterococcus faecalis lipoteichoic acid. J Endod (2012) 0.81
Correlated expression of human beta defensin-1, -2 and -3 mRNAs in gingival tissues of young children. Arch Oral Biol (2004) 0.81
Specificity of antimicrobial peptide LL-37 to neutralize periodontopathogenic lipopolysaccharide activity in human oral fibroblasts. J Periodontol (2012) 0.79
Oral fibroblasts produce more HGF and KGF than skin fibroblasts in response to co-culture with keratinocytes. APMIS (2002) 0.79
The antimicrobial peptide LL-37 is anti-inflammatory and proapoptotic in human periodontal ligament cells. J Periodontal Res (2011) 0.78
Antibiotic-induced Porphyromonas gingivalis LPS release and inhibition of LPS-stimulated cytokines by antimicrobial peptides. Peptides (2010) 0.77
Subinhibitory concentrations of triclosan promote Streptococcus mutans biofilm formation and adherence to oral epithelial cells. PLoS One (2014) 0.82
Tea polyphenols inhibit the activation of NF-κB and the secretion of cytokines and matrix metalloproteinases by macrophages stimulated with Fusobacterium nucleatum. Sci Rep (2016) 0.78
Tea polyphenols inhibit the growth and virulence properties of Fusobacterium nucleatum. Sci Rep (2017) 0.75